三甘油糖指数作为晚期胃癌的预后指标:洞察力和未来的研究
Cheng-Fei Zhao1,2, Xiao-Ling Liu1, Ning-Bi Wu1
1School of Pharmacy and Medical Technology, Putian University, Putian 351100, Fujian Province, China.
World journal of gastroenterology
|June 16, 2025
概括
甘油三糖 (TyG) 指数显示,作为晚期胃癌患者接受免疫疗法和化疗的预后标志物具有前途. 较高的TyG指数值与改善的生存结果相关,有助于个性化治疗策略.
科学领域:
- 在瘤学瘤学.
- 代谢综合征是代谢综合征的一种.
- 生物标志物发现发现
背景情况:
- 晚期胃癌 (GC) 存在重大治疗挑战,尽管免疫疗法取得了进展,但预后不佳.
- 迫切需要可靠的预后标志物来指导高级GC的治疗决策.
- 作为胰岛素耐药性的标志物,甘油三糖 (TyG) 指数正在研究其预后潜力.
更多相关视频
相关概念视频
01:15Hypoglycemia and Glucagon
353
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
353
01:24Glucagon-like Receptor Agonists
438
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
438